Anterix Inc has a consensus price target of $60 based on the ratings of 4 analysts. The high is $75 issued by B. Riley Securities on February 16, 2024. The low is $41 issued by Morgan Stanley on August 1, 2023. The 3 most-recent analyst ratings were released by JP Morgan, B. Riley Securities, and Morgan Stanley on August 8, 2024, February 16, 2024, and August 1, 2023, respectively. With an average price target of $59 between JP Morgan, B. Riley Securities, and Morgan Stanley, there's an implied 84.95% upside for Anterix Inc from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for Anterix (NASDAQ:ATEX) was reported by JP Morgan on August 8, 2024. The analyst firm set a price target for $61.00 expecting ATEX to rise to within 12 months (a possible 91.22% upside). 2 analyst firms have reported ratings in the last year.
The latest analyst rating for Anterix (NASDAQ:ATEX) was provided by JP Morgan, and Anterix maintained their overweight rating.
There is no last upgrade for Anterix
There is no last downgrade for Anterix.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Anterix, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Anterix was filed on August 8, 2024 so you should expect the next rating to be made available sometime around August 8, 2025.
While ratings are subjective and will change, the latest Anterix (ATEX) rating was a maintained with a price target of $60.00 to $61.00. The current price Anterix (ATEX) is trading at is $31.90, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.